Watch Out! This Activist Investor May Put Pressure On These 3 High-Yielding Stocks
Trian Partners was founded in 2005 by activist investor Nelson Peltz, who has a history of buying up shares, securing board seats and orchestrating M&A deals.
Pfizer Resumes Dosing In Phase 3 Hemophilia Gene Therapy Trial Six Months After FDA Lifts Clinical Hold
Pfizer Inc (NASDAQ:PFE) and its partner Sangamo Therapeutics Inc (NASDAQ:SGMO) have reopened enrollment in phase 3 AFFINE study hemophilia A gene therapy trial. …
AstraZeneca Pulls Plug On Ionis Pharma-Partnered Cholesterol Med
Ionis Pharmaceuticals Inc (NASDAQ:IONS) announced topline data from the Phase 2b SOLANO study of ION449 (AZD8233) for hypercholesterolemia (high cholesterol levels).…
Qualcomm Partners With Mercedes-Benz, Red Hat On Automotive Tech: What Investors Need To Know
Qualcomm Inc (NASDAQ: QCOM) unveiled partnerships with top manufacturers to propel the development of the next generation of connected vehicles Thursday at its Automotive Investor Day.
Luna Innovations Shares Pop After New Contract With Medtech Giant Intuitive Surgical
Luna Innovations Inc (NASDAQ:LUNA) announced a new $14.2 million contract with its long-standing partner Intuitive Surgical Inc (NASDAQ:ISRG). This new agreement provides for…
Novo Nordisk’s Experimental Diabetes Treatment Achieves Better Blood Sugar Targets Than Insulin Degludec
Novo Nordisk A/S (NYSE:NVO) presented new data from the phase 3a ONWARDS 2 trial of insulin icodec in type 2 diabetes…
Pfizer To Supply 6M COVID-19 Therapy Courses To Low Income Countries
Pfizer Inc (NYSE:PFE) would supply up to 6 million courses of its COVID-19 antiviral treatment to NGO Global Fund for low-…
FDA Approves Lilly’s Retevmo, the First and Only RET Inhibitor For Solid Tumor Indications
The FDA has approved Eli Lilly And Co’s (NYSE:LLY) Retevmo (selpercatinib, 40 mg & 80 mg capsules) for solid tumors. The…
